Nobel Prize Recognizes Groundbreaking Body's Defenses Research
The prestigious award in medical science has been granted for revolutionary discoveries that clarify how the body's defense network attacks dangerous infections while protecting the body's own cells.
A trio of renowned scientists—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this honor.
The research uncovered specialized "sentinels" within the immune system that eliminate rogue defense cells capable of harming the organism.
These discoveries are now enabling new treatments for immune disorders and cancer.
These laureates will share a prize fund worth 11m SEK.
Decisive Findings
"Their work has been essential for comprehending how the body's defenses operates and why we don't all develop serious autoimmune diseases," stated the chair of the Nobel Committee.
The trio's research explain a fundamental question: In what way does the immune system protect us from countless infections while leaving our healthy cells intact?
The body's protection system employs immune cells that scan for indicators of disease, including viruses and germs it has never encountered.
Such defenders employ detectors—called receptors—that are produced by chance in countless variations.
That provides the defense network the ability to combat a broad range of invaders, but the randomness of the mechanism inevitably creates white blood cells that may attack the body.
Security Guards of the Body
Researchers earlier understood that a portion of these harmful defense cells were destroyed in the immune organ—where immune cells develop.
The latest award honors the identification of regulatory T-cells—known as the immune system's "security guards"—which travel through the system to neutralize other defenders that attack the healthy cells.
It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and RA.
A prize committee stated, "These findings have laid the foundation for a new field of research and accelerated the creation of innovative therapies, for example for cancer and immune disorders."
Regarding cancer, regulatory T-cells prevent the body from attacking the growth, so studies are focused on lowering their numbers.
For autoimmune diseases, experiments are exploring boosting T-reg cells so the body is not being harmed. A comparable approach could also be useful in reducing the chances of organ transplant failure.
Pioneering Experiments
Prof Sakaguchi, from Osaka University, conducted experiments on rodents that had their thymus removed, leading to autoimmune disease.
The researcher demonstrated that introducing immune cells from healthy mice could stop the disease—suggesting there was a mechanism for blocking immune cells from attacking the host.
Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, currently at a biotech firm in a California city, were investigating an genetic immune disorder in rodents and people that led to the discovery of a gene critical for the way T-regs function.
"The pioneering work has revealed how the immune system is controlled by T-reg cells, preventing it from accidentally targeting the body's own tissues," commented a prominent biological science expert.
"The work is a remarkable illustration of how basic biological research can have far-reaching implications for human health."
